Dental biomaterials are used to stop tissue regeneration and repair injured tooth tissues. Many dental professionals employ biomaterials for dental treatment, and these materials have recently been studied and developed. In order to speed up biological processes and replace missing tooth tissues, various biomaterials have been created. The mineral hydroxyapatite, for instance, is made up of calcium and phosphate ions. The market for dental biomaterials will grow at a strong CAGR of 7.29%, from a value of $7.70 billion in 2021 to $14.5 billion by 2030.
The market is fueled by factors such as the rising elderly population, the rising frequency of dental problems, the rising demand for aesthetic dentistry, the rising costs of dental and oral care, and the increased use of innovative adhesives, resin cement in CAD/CAM, and other digital technologies.
Oral problems’ rising prevalence is anticipated to fuel market expansion.
The market is expanding because of oral problems such as tooth decay, periodontal disease, oral cancer, dental caries, and halitosis. The Centers for Disease Control and Prevention estimate that 46% of people aged 30 and older have gum disease symptoms, with 9% of adults suffering from severe gum disease. About 26% of people in the United States have untreated tooth rot. Furthermore, the National Institute of Dental and Craniofacial Research reports that dental caries affects permanent teeth in 92 percent of adults between the ages of 20 & 64, with an average severity of 3.28 missing or decayed permanent teeth and 13.65 missing or decayed permanent teeth. Dental implants are becoming more widely recognized in the middle- and low-income countries, which will spur market expansion throughout the projection period. In addition, the demand for aesthetic operations like teeth whitening and gum contouring has expanded along with the increase in disposable wealth in industrialized nations.
The market will be constrained in the forecast period by high treatment costs, strict regulatory and clinical processes, and low insurance reimbursement coverage.
In 2021, the metallic biomaterials sector ruled the dental biomaterials market. Due to the growing popularity of dental implants and procedures, the ceramic dental biomaterials market is expanding. Due to the expanding aging populations in developed countries and patients’ desire to maintain their participation and standard of living, the use of implants has significantly expanded in recent years. As a result, the use of high-quality implantable biomaterials that can address certain dental problems has steadily increased.
In 2021, the orthodontics segment had the highest revenue share at 43%. Due to the rise in dental conditions and tooth decay, there is an increasing need for dental biomaterials in orthodontics. Additionally, increased disposable income and the tendency toward medical tourism propel this market’s expansion globally. Due to the increased popularity of dental implants, there is also a developing market for dental biomaterials used in orthodontics.
End Use Insights
In 2021, the dental laboratories market sector held a 38% market share. Dental biomaterials for dental laboratories are expanding as a result of reasons including rising dental diseases and infections, rising consumer awareness of oral hygiene and health, and rising demand for dental implants and procedures. Additionally, expanding research and development activities worldwide are credited with contributing to the growth of the dental biomaterials market.
In 2021, North America held a 37% sales share in the dental biomaterials market. Growing dental problems are one of the major reasons propelling the market for dental biomaterials in North America. Over 5 million Americans aged 65 to 74 have lost all of their teeth, including over 3 million who are edentulous, as per American Dental Association 2020. On the other hand, tooth loss is mostly an issue for elderly people. This is because 27% of people with dental caries who are 20 to 64 years old go undetected. Government initiatives and an increasing senior population are further factors boosting the area industry.
Key Players analysis
Key market participants in the dental biomaterials industry include Straumann AG, Henry Schein, Inc., Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Mitsui Chemicals, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc.